DJIA 16,082.65 68.27 0.43%
NASDAQ 4,340.17 71.41 1.67%
S&P 500 1,870.23 18.02 0.97%
market minute promo

89.91 2.96 (3.40%)

REAL-TIME: Last trade at

company name or ticker

Recent Quotes

VRX $89.91 3.40%
Company Photos
(Click to zoom)
1D 1W 3M 6M 1Y 2Y 3Y
Today's Open $88.25
Previous Close $86.95
Daily Range $86.88 - $90.72
52-Week Range $69.33 - $263.81
Market Cap $30.8B
P/E Ratio 49.40
Dividend (Yield) $0.00 (0.0%)
Volume 690,173
Average Daily Volume 7,251,330
Current FY EPS $2.96




Drug Makers

Valeant Pharmaceuticals (VRX) Description

A global specialty pharmaceutical company that develops, manufactures and markets a range of pharmaceutical products, primarily in the areas of neurology, infectious disease, and dermatology. Website:

News & Commentary Rss Feed

3 Reasons Valeant Pharmaceuticals Intl. Inc. Was Clobbered in January

Following an 11% tumble in January, can you trust Valeant, which appears to be trading at a bargain-basement price?

No Super Bowl bump for Fitbit. Stock at all-time low

No Super Bowl bump for Fitbit. Stock tanks

In Vast Difference From Berkshire Style, Lou Simpson Adds to Valeant Position

3 Stocks Dragging The Health Care Sector Downward

Lou Simpson Adds to Valeant Stake

Valeant's Share Price Continues to Decline

So, Bill Ackman Makes Some Good Points on the Index Bubble . . .

Whitney Tilson's New Emails to Partners

PDL BioPharma: Even After The Dividend Cut, 50% Further Downside Is Possible

Valeant: Shorts In The Cold

See More VRX News...

VRX's Top Competitors

VRX $89.91 (3.40%)
Current stock: VRX
JNJ $102.35 (0.37%)
Current stock: JNJ
NVS $73.82 (1.65%)
Current stock: NVS
RHHBY $31.55 (1.32%)
Current stock: RHHBY